Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

6 3 月, 2026

One Min Read

19 Views

原文: https://finance.yahoo.com/news/guggenheim-raises-price-target-arcutis-152048008.html

Last Update: 6 3 月, 2026

Written By

Other Articles

Previous

RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating

Next

Truist Raises Its Price Target on CoreWeave, Inc. (CRWV) to $85 and Maintains a Hold Rating

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept